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1. Introduction 
Many of the properties of the plasma membrane 
glycoproteins have been ~vestigated by using several 
lectins, including concanavalin A (con A). Although 
the precise mechanism of lectin action on the cell 
surface is not known, interaction of con A with plasma 
membrane involves the recognition of sugar esidues 
[I]. Moreover, the binding of con A to cell surface 
macromolecules can be specifically reversed by the 
addition of a-methyl-D-mannoside or a-methyl-D- 
glucoside [2]. The interactions of con A with plasma 
membranes have been shown to cause a number of 
biological effects including cell agglutination [3], 
transformation of lymphocytes [4] and mitotic induc- 
tion [5] and to affect membr~e enzyme activities 
such as 5’-nucleotidase [6], ATPase [7 ] and sialyl- 
transferase [8]. Con A has also been found to modify 
the binding [9-l l] or the activity [ 12-141 of certain 
hormones, and to mimic several hormonal effects 
[15,16]. 
Here we demonstrate hat con A is able to inhibit 
the basal and stimulated hormone release by rat 
pituitary cells in culture. 
2. Materials and methods 
Culture medium and fetal calf serum were obtained 
from GibcoBiocult (Paisley). [3H] Leucine, [3H] - 
glucosamine and [3H]thymidine were from CEA 
(Saclay). Plastic Petri dishes were purchased from 
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Falcon Plastics Co. (Oxnard, CA). Thyrotropin 
releasing hormone (TRH) was obtained from UCB 
(Brussels) and GnRH was a generous gift of Dr R. 
Studer from Hoffman La Roche (Basel). Con A was 
from Pharmacia (Uppsala) and a-methyl-D-mannoside 
from Sigma (St Louis, MO). All other chemicals were 
of reagent grade. 
Dispersed rat anterior pituitary cells in monolayer 
cultures were prepared according to [ 171. After dis- 
persion, the cells were suspended in medium F-10 
with the addition of fetal calf serum (2.5%) rat 
serum (15%), N,2-hydroxyethylpiperazine&,2ethane 
sulfonic acid (Hepes, 25 mM) and a mixture of anti- 
biotics (50 IU penicill~/ml, 50 ,ctg streptomycin/ml 
and 2.5 c(g fungizone/ml). Each Petri dish was seeded 
with 4-8 X 10’ cells in 1 ml/culture medium. Usually 
5 dishes/group were used. The cells were used on 
day 5 of the culture when adrenocorticotrophic 
hormone (ACTH), thyroid stimulating hormone 
(TSH), prolactin (PRL) and growth hormone (GH) 
release were studied. For follicle stimulating hormone 
(FSH) and luteinizing hormone (LH) studies, the 
cultures were used on day 7 with a change of medium 
on day 4. After washing the cells, the incubations 
were carried out in the synthetic medium F-10 for 
4 h. For the studies with high K’, the cells were incu- 
bated in Krebs-Ringer bicarbonate buffer containing 
59 mM K’ (instead of Na”), 16 mM glucose and 15 
mM Hepes. 
2.2. R~i~irnrnu~oass~~ 
Radioimmunoassays for rat TSH, PRL and GH 
were performed using kits provided by the NIAMDD 
rat pituitary hormone distribution program. ACTH 
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was radioimmunoassayed according to [ 181, using 
antiserum kindly provided by Dr Vaudry. LH and 
FSH were estimated by radioimmunoassay as in [ 191, 
using anti-ovine LyO and anti-ovine FSH obtained 
from Dr Kerdelhue (this laboratory). Our own prep- 
arations of rat LH (1.26 X NIH-LH-Sr) and rat FSH 
(37.60 X NIH-FSH-Sr) were used as standard prep- 
arations. 
2.3. Incorporation of labelled precursors 
After incubation in the presence of labelled 
precursors (2.5 &i/dish), the cells were washed and 
0.5 ml water were added. The dishes were frozen and 
thawed. The broken cells were detached with a rubber 
policeman, transferred into test tubes and centrifuged 
at 2000 X g for 20 min. The clear supernatants were 
used for measuring the incorporation of [3H]leucine 
and [3H]glucosamine into trichloroacetic acid-precip- 
itable proteins and for measuring the incorporation of 
[3H] thymidine into deoxyribonucleic acid (DNA) 
WI. 
2.4. Hypothalamic extracts 
Lyophilised hypothalamic extracts (HE) used for 
ACTH studies [21] were dissolved in phosphate- 
buffered saline so that the equivalent of 0.2 hypo- 
thalamus/dish was added. 
3. Results 
As shown in tig.1, both basal and GnRH-stimulated 
FSH release were inhibited by con A in a dose-related 
manner. At 100 pg/ml, con A was able to decrease 
the basal FSH release by -90% and to completely 
inhibit the releasing action of GnRH. The inhibition 
patterns of the basal and stimulated release of LH, 
TSH, ACTH, GH and PRL, observed in the presence 
of con A, were dose-related in a similar way (not 
shown). 
Whatever the secretagogue used, physiological 
(TRH, GnRH, HE) or pharmacological (8 Br-CAMP, 
high K’), con A was able to decrease the release of 
each pituitary hormone tested (fig.2). The effect of 
con A was partially reversed by a-methyl-D-mannoside 
(1 mg/ml). In contrast, con A was unable to modify 
the incorporation of [ 3H] leucine and [ 3H] glucosamine 
into trichloroacetic acid-precipitable proteins and the 
incorporation of [3H]thymidine into DNA (table 1). 
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Fig.1. Effect of increasing concentrations of con A on the 
basal (o---o) and the GnRH (9 ng/ml) (o-o) induced 
release of FSH by pituitary cells in culture, during a 4 h incu- 
bation. 
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Fig.2. Effect of con A (50 Mg/ml) on the basal and stimulated 
hormone release by pituitary cells in culture during 4 h incu- 
bations. LH and FSH release was stimulated by GnRH (9 ng/ 
ml), that of TSH by TRH (10 ng/ml), 59 mM K+and 8 Br- 
CAMP (1 mM), that of ACTH by HE (0.2 hypothalamus/ 
dish), 59 mM K’ and 8 Br-cAMP (3 mM), that of PRL by 
TRH (10 ng/ml) and 59 mM K’ and that of GH by 8 Br- 
CAMP (1 mM). The concentration of or-methyl-D-mannoside 
was 1 mg/ml. 
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Table 1 
Lack of effect of con A (100 ng/ml) on the incorporation of [ ‘Hlleucine and 
[ 3H]glucosamine into trichloroacetic acid-precipitable proteins and on the incor- 
poration of [‘HI thymidine into DNA 
May 1980 
Group Incorporation of 
[‘H ] Leucine 
into proteins 
(cpm) 
[ 3H]Glucosamine 
into proteins 
(cpm) 
[‘H]Thymidine 
into DNA 
(cpm) 
Control 135 502 f. 9363 13 855 ? 1182 88186+ 3749 
Con A 148832t13157 17 351 r 372 86895 +6815 
(100 r&l) 
The incubations were carried out for 4 h in the presence of the labelled precursors 
(2.5 &i/ml) 
4. Discussion 
This paper shows that con A is able to decrease the 
hormone release from rat pituitary cell cultures. This 
was true for every hormone tested. The effect of 
con A was dose-related and partially reversed by (Y- 
methyl-D-mannoside. 
Con A has been demonstrated to inhibit the bind- 
ding of prolactin to mammary tumors [9] and to 
particulate fractions of rat liver [lo]. The binding of 
insulin to both intact cells and solubilized receptors 
was also inhibited by con A [ 111. In contrast, con A 
had a protective effect on the stimulation of the 
adenylate cyclase activity of adrenocortical plasma 
membranes, by ACTH [ 121, whereas it facilitated 
[ 13,141 or decreased [141 the in vitro thyroid activa- 
tion by TSH, depending on lectin concentration. 
Taking these results into account, one could postulate 
that the inhibition of the pituitary hormone release 
observed here was due to an alteration by con A of 
the binding of the hypothalamic releasing hormones 
tested (TRH, GnRH and CRF from HE) to their spe- 
cific receptors. However this explanation cannot 
account for the inhibition of the hormone release 
stimulated by either 59 mM K’ or 8 Br-CAMP. It 
could be thought that the permeability of the pituitary 
cells to both K+ and 8 Br-CAMP was decreased because 
of a major alteration of the plasma membrane trans- 
port processes by con A. This is unlikely since our 
results showed that the incorporation of [3H]leucine 
and [3H]glucosamine into trichloroacetic acid-precip- 
itable proteins, and the incorporation of [3H]- 
thymidine into DNA were not altered by con A, 
indicating that the membrane transport of amino 
acids, carbohydrates and nucleotides were not modi- 
fied. Since the release of each pituitary hormone 
tested was decreased by con A, whatever the secreta- 
gogues used, an alternative explanation for our results 
would be that con A acted at the hormone release 
level. This would be in good agreement with the fact 
that the basal hormone release was also inhibited by 
the lectin. Therefore, our results suggest hat in addi- 
tion to its effect on the interactions of certain hor- 
mones with their receptors [9-141, con A may alter 
the function of other carbohydrate containing mem- 
brane components involved in the transport of hor- 
mones across the plasma membrane, during their 
release. 
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